TGTX
NASDAQStockTG Therapeutics, Inc.
$26.96-1.09 (-3.89%)
52-Week Range
$26.39
$45.51
Key Stats
Market Cap
4.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.86
Volume
1.2M
Avg Volume
1.9M
Performance
1M
-6.52%
3M
-14.23%
6M
-15.15%
YTD
-7.99%
1Y
-27.31%
3Y
+81.05%
5Y
-43.99%
Price Chart
ETF Exposure
TGTX is held by 118 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| AOK | iShares Core 30/70 Conservative Allocation ETF | 0.00% |
| AOM | iShares Core 40/60 Moderate Allocation ETF | 0.00% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| VLU | State Street SPDR S&P 1500 Value Tilt ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 3 of 3
About TGTX ETF Exposure
TG Therapeutics, Inc. (TGTX) is held by 118 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.3B, TGTX is a widely held institutional stock. The stock currently trades at $26.96. Investors can gain exposure to TGTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TGTX, sorted by portfolio weight.